Apotex Case Shows Inequitable Conduct Is Still A Potent Tool

By Ryan Davis (August 19, 2014, 9:59 PM EDT) -- A recent Federal Circuit ruling that an Apotex Inc. patent is unenforceable because of misconduct by the company's chairman makes clear that although a 2011 decision made inequitable conduct very difficult to prove, the defense can still deliver sweeping wins for accused infringers under the right circumstances, attorneys say....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!